# Non-communicable disease care for persons living with HIV in Peru: A national physician cross-sectional study

**Authors:** Rebecca Slotkin, Daniel Granda, Diego Cabrera, Carlos Manuel Benites, Patricia J. Garcia, Evelyn Hsieh

PMC · DOI: 10.1371/journal.pgph.0004846 · PLOS Global Public Health · 2025-08-04

## TL;DR

This study explores how Peruvian HIV physicians manage non-communicable diseases in their patients and identifies gaps in confidence and guidelines.

## Contribution

The study provides the first national data on NCD management practices among HIV physicians in Peru.

## Key findings

- Most physicians encounter NCDs like hyperlipidemia and hypertension in their HIV patients.
- Physicians feel least confident managing neurocognitive impairment and sarcopenia.
- Screening aligned with existing guidelines is more common than screening beyond them.

## Abstract

Non-communicable diseases (NCDs) are a significant cause of morbidity and mortality for the aging HIV population worldwide. In Peru, no data exists on how providers address NCDs for persons living with HIV (PLWH). This study examines HIV physician confidence and current management practices for NCDs for PLWH in Peru. We recruited public-sector HIV physicians via Peru’s National HIV, STI and Hepatitis Program’s (NHSTIHP) physician registry and by program coordinator referral. Participants completed a telephone survey encompassing seven NCDs [hyperlipidemia, hypertension, diabetes, osteoporosis, sarcopenia, non-AIDS defining cancers, neurocognitive impairment (NCI)] and three modifiable risk factors (obesity, tobacco, and alcohol use). Survey domains included: (1) provider and practice characteristics (2) NCDs encountered, (3) provider confidence in prevention, diagnosis, and treatment (based upon a four-point Likert scale), (4) screening frequency and management approaches (free response). We obtained contact information from 167 physicians working with the NHSTIHP, and 78 (47%) volunteered to participate (mean age 45.8 ± 9.3 years; 26% women; 78% infectious disease trained) across 23 of the 25 regions of Peru. The majority (>50%) of physicians reported at least one patient with: hyperlipidemia, hypertension, diabetes, NCI, cervical cancer, obesity, tobacco, and/or alcohol use. Physicians felt most confident independently managing metabolic disorders (hyperlipidemia, diabetes, hypertension, obesity), and least confident with NCI and sarcopenia. Most physicians (>50%) would manage the NCDs, although management approaches differed. NCD screening that was part of the NHSTIHP National HIV care guidelines was more consistently performed than screening beyond the scope of the existing guidelines. Peruvian HIV physicians encounter NCDs in their patient population and manage these conditions and risk factors despite variable confidence and/or knowledge of best practices. This study highlights opportunities for expanding physician education, addressing systems-level barriers to NCD care, and the need for locally relevant, epidemiologically-based, HIV-specific NCD care guidelines.

## Linked entities

- **Diseases:** hyperlipidemia (MONDO:0021187), diabetes (MONDO:0005015), osteoporosis (MONDO:0005298), cervical cancer (MONDO:0002974), obesity (MONDO:0011122)

## Full-text entities

- **Diseases:** Hepatitis (MESH:D056486), hyperlipidemia (MESH:D006949), STI (MESH:D012749), infectious disease (MESH:D003141), sarcopenia (MESH:D055948), cancers (MESH:D009369), metabolic disorders (MESH:D008659), cervical cancer (MESH:D002583), hypertension (MESH:D006973), obesity (MESH:D009765), NCDs (MESH:D000073296), neurocognitive impairment (MESH:D019965), HIV (MESH:D015658), non-AIDS defining (MESH:D000163), diabetes (MESH:D003920), osteoporosis (MESH:D010024)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12321123/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12321123/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12321123/full.md

---
Source: https://tomesphere.com/paper/PMC12321123